The DOI matches its Crossref record.
MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
DNA hypermethylation in tumorigenesis: epigenetics joins genetics
Baylin, S. B., & Herman, J. G. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01971-x · Cited by 1,628
Self-citationPromoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors
Esteller, M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.7.564 · Cited by 1,233
Self-citationCpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future
Esteller, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205600 · Cited by 1,233
Self-citationAberrant patterns of DNA methylation, chromatin formation and gene expression in cancer
Baylin, S. B. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.687 · Cited by 929
Self-citationDavoli, T., Xu, A. W., Mengwasser, K. E., Sack, L. M., Yoon, J. C., Park, P. J., & Elledge, S. J. (2013) · Cell · doi:10.1016/j.cell.2013.10.011 · Cited by 815
Genetic susceptibility to non-polyposis colorectal cancer
Lynch, H. T., & de la Chapelle, A. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.11.801 · Cited by 814
Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours
Esteller, M., & Herman, J. G. (2002) · The Journal of Pathology · doi:10.1002/path.1024 · Cited by 743
Self-citationDNA MISMATCH REPAIR AND GENETIC INSTABILITY
Harfe, B. D., & Jinks-Robertson, S. (2000) · Annual Review of Genetics · doi:10.1146/annurev.genet.34.1.359 · Cited by 608
ABERRANT DNA METHYLATION AS A CANCER-INDUCING MECHANISM
Esteller, M. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095832 · Cited by 549
Self-citationMolecular and Pathologic Aspects of Endometrial Carcinogenesis
Hecht, J. L., & Mutter, G. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.7173 · Cited by 535
Costello, J. F., & Plass, C. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.5.285 · Cited by 442
Laird, P. W. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi113 · Cited by 398
Lax, S. F. (2004) · Virchows Archiv · doi:10.1007/s00428-003-0947-3 · Cited by 378
Relevance of DNA methylation in the management of cancer
Esteller, M. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01115-x · Cited by 329
Self-citationDNA Methylation: An Alternative Pathway to Cancer
Wajed, S. A., Laird, P. W., & DeMeester, T. R. (2001) · Annals of Surgery · doi:10.1097/00000658-200107000-00003 · Cited by 327
Esteller, M., & Herman, J. G. (2004) · Oncogene · doi:10.1038/sj.onc.1207316 · Cited by 326
Self-citationSimpkins, S. B., Bocker, T., Swisher, E. M., Mutch, D. G., Gersell, D. J., Kovatich, A. J., Palazzo, J. P., Fishel, R., & Goodfellow, P. J. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.661 · Cited by 319
hMLH1 Promoter Hypermethylation Is an Early Event in Human Endometrial Tumorigenesis
Esteller, M., Catasus, L., Matias-Guiu, X., Mutter, G. L., Prat, J., Baylin, S. B., & Herman, J. G. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65492-2 · Cited by 304
Self-citationEpigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance
Wilting, R. H., & Dannenberg, J.-H. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.01.008 · Cited by 303
Molecular pathology of endometrial hyperplasia and carcinoma
Matias-guiu, X., Catasus, L., Bussaglia, E., Lagarda, H., Garcia, A., Pons, C., Muñoz, J., Argüelles, R., Machin, P., & Prat, J. (2001) · Human Pathology · doi:10.1053/hupa.2001.25929 · Cited by 301
Prognostic parameters of endometrial carcinoma
Prat, J. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.02.007 · Cited by 287
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer
Lanza, G., Ferracin, M., Gafà, R., Veronese, A., Spizzo, R., Pichiorri, F., Liu, C.-G., Calin, G. A., Croce, C. M., & Negrini, M. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-54 · Cited by 285
Broaddus, R. R., Lynch, H. T., Chen, L., Daniels, M. S., Conrad, P., Munsell, M. F., White, K. G., Luthra, R., & Lu, K. H. (2006) · Cancer · doi:10.1002/cncr.21560 · Cited by 285
Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis
Herceg, Z., & Hainaut, P. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.01.004 · Cited by 282
Endometrial Cancer and Lynch Syndrome: Clinical and Pathologic Considerations
Meyer, L. A., Broaddus, R. R., & Lu, K. H. (2009) · Cancer Control · doi:10.1177/107327480901600103 · Cited by 281
DNA Methylation Profiling: An Emerging Paradigm for Cancer Diagnosis
Papanicolau-Sengos, A., & Aldape, K. (2022) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-042220-022304 · Cited by 279
DNA Damage Response Genes and the Development of Cancer Metastasis
Broustas, C. G., & Lieberman, H. B. (2014) · Radiation Research · doi:10.1667/rr13515.1 · Cited by 275
Das, V., Kalita, J., & Pal, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.064 · Cited by 275
Chakravarty, D., Johnson, A., Sklar, J., Lindeman, N. I., Moore, K., Ganesan, S., Lovly, C. M., Perlmutter, J., Gray, S. W., Hwang, J., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02767 · Cited by 266
Quantitation of Promoter Methylation of Multiple Genes in Urine DNA and Bladder Cancer Detection
Hoque, M. O., Begum, S., Topaloglu, O., Chatterjee, A., Rosenbaum, E., Van Criekinge, W., Westra, W. H., Schoenberg, M., Zahurak, M., Goodman, S. N., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj265 · Cited by 262
Epigenetic lesions causing genetic lesions in human cancer
Esteller, M. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00303-8 · Cited by 258
Self-citationMethylated DNA collected by tampons: a new tool to detect endometrial cancer.
Fiegl, H., Gattringer, C., Widschwendter, A., Schneitter, A., Ramoni, A., Sarlay, D., Gaugg, I., Goebel, G., Müller, H. M., Mueller-Holzner, E., et al. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.882.13.5 · Cited by 123
Metadata
- Authors
- Esteller, M., Levine, R., Baylin, S. B., Ellenson, L. H., & Herman, J. G.
- Venue
- Oncogene
- Published
- 1998-10-10
- Volume
- 17
- Issue
- 18
- Pages
- 2413-2417
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2034066784
- Cited by
- 493
- References
- 0
- FWCI
- 19.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.